DeutschNewstral
Teva Pharms
The Growing Causal Divide: But-For Causation in AKS/FCA Actionsjdsupra.com- Latest Precedential Claim Construction Casesjdsupra.com
- “A”/“An” Means “One or More,” Said the Federal Circuit…Againjdsupra.com
- In re Theripion (Fed. Cir. 2023)jdsupra.com
- Previewing Generic’s Skinny Label: Supreme Court to Rule on Teva’s Certiorari Petitionjdsupra.com
- Vanda Pharms. Inc. v. Teva Pharms. USA, Inc. Hetlioz® (Tasimelteon)jdsupra.com
- Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decisionjdsupra.com
- Latest Federal Court Cases - April 2023 #2jdsupra.com
- Amgen Files Reply Brief in Amgen v. Sanofijdsupra.com
- Vanda Pharms., Inc. v. Teva Pharms. USA, Inc.jdsupra.com
- Vifor Fresenius Medical Care Renal Pharma Ltd. v. Teva Pharms. USA, Inc.jdsupra.com
- Novartis Pharmaceuticals Corp. v. Accord Healthcare, Inc. (Fed. Cir. 2022)jdsupra.com
- Adapt Pharma Operations Ltd. v. Teva Pharms. USA, Inc. Narcan® (Naloxone)jdsupra.com
- GlaxoSmithKline LLC v. Teva Pharms. USA, Inc.jdsupra.com
- D. Del. Says ANDA Specification Trumps All Else in Infringement Analysisjdsupra.com
- Federal Circuit Dissent Declares “No Skinny-Label Generic is Safe”jdsupra.com
- Janssen Pharms., Inc. v. Teva Pharms. USA, Inc.jdsupra.com
- Just Skinny Enough: District Court Dismisses Inducement Claims Against Generic “Skinny Label”jdsupra.com
- REGENXBIO v. SAREPTA: Make Sure You’re Safely Within the Safe Harbor Before Using a “Research Tool”jdsupra.com
- Biosimilars 2021 Year in Reviewjdsupra.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.